source
- Merck KGaA sees client stockpiling of lab equipment amid Iran war, lifts guidanceMerck KGaA's CFO Helene von Roeder said the company is observing a rise in demand for its laboratory equipment as customers increase inventories in response to the ongoing war in Iran. The heighte…
- Safety-boosting drug may weaken gene therapy efficacy in Dravet syndrome trialEncoded Therapeutics studied a drug meant to improve the safety of gene therapy in children with Dravet syndrome, a severe genetic epilepsy. In the trial of 21 participants, most received steroids…